Skip to content
Review

B-247 Associations between renal function, hepatic fibrosis indices, and metabolic biomarkers across two decades of NHANES data

Oct 2026 · Clinical Chemistry · 0 citations

TL;DR

In a large, nationally representative cohort, renal function exhibited stable and significant inverse associations with non-invasive hepatic fibrosis indices across nearly two decades, highlighting population-level coupling between kidney function, hepatic risk scores, and metabolic traits.

Abstract

Chronic kidney disease (CKD), metabolic dysfunction, and chronic liver disease frequently coexist and share overlapping cardiometabolic risk factors. Non-invasive hepatic fibrosis indices are widely used for liver risk stratification, yet their population-level relationships with renal function remain incompletely characterized. We investigated associations between estimated glomerular filtration rate (eGFR), hepatic fibrosis scores, and metabolic biomarkers in a nationally representative cohort. Data from nine consecutive National Health and Nutrition Examination Survey (NHANES) cycles (1999–2000 through 2015–2016) were analyzed. Renal function was estimated using the CKD-EPI 2021 creatinine equation. Hepatic fibrosis indices included Fibrosis-4 (FIB-4), NAFLD fibrosis score (NFS), Forns index, AST-to-platelet ratio index (APRI), BARD score, and GGT-to-platelet ratio (GPR). Associations were evaluated using Spearman (rho) and Pearson (r) correlations. Group differences across fibrosis score categories were assessed using one-way ANOVA or two-sample t-tests. Analyses used pairwise complete-case observations. Across NHANES cycles and in the combined dataset (up to n about 51,000), eGFR demonstrated consistent inverse correlations with hepatic fibrosis indices. The strongest associations were observed for the Forns index (Spearman rho range: approximately -0.72 to -0.85 across cycles; combined rho about -0.75) and FIB-4 (rho approximately -0.72 to -0.82; combined rho about -0.75). NFS showed moderate inverse correlations (combined rho about -0.64). Weaker but statistically significant inverse associations were observed for APRI, BARD, and GPR (all p < 0.001). Categorical analyses revealed stepwise reductions in eGFR across low, indeterminate, and high fibrosis risk strata for Forns index, FIB-4, NFS, APRI, and GPR (ANOVA p < 0.001). Participants in higher fibrosis categories exhibited lower median eGFR. eGFR also correlated with metabolic and clinical chemistry parameters. Inverse associations were observed with HbA1c, fasting plasma glucose, body mass index, GGT, and total cholesterol, whereas positive associations were observed with serum albumin and platelet count. These patterns were directionally consistent across survey cycles. In a large, nationally representative cohort, renal function exhibited stable and significant inverse associations with non-invasive hepatic fibrosis indices across nearly two decades. These findings highlight population-level coupling between kidney function, hepatic risk scores, and metabolic traits. Further studies are warranted to determine the mechanisms underlying these associations.

View source

Similar papers

Open access Oct 2026

Effect of uric acid and estimated glomerular filtration rate on the Fibrosis-4 index

Hepatic steatosis and fibrosis present a significant public health burden, especially in China. Emerging evidence suggests an association between liver fibrosis and kidney function, indicating a potential relationship among uric acid (UA) levels, estimated glomerular filtration rate (eGFR), and the Fibrosis-4 (FIB-4) i...

Wei-Na Xu, Dan-Xiang Chen, Saiyun Lou et al. · 0 citations
Review Open access Sep 2026

Associations Between Urinary Metabolic Indicators and Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis: Evidence from National Health and Nutrition Examination Survey 2017-2020.

Background/Aims Metabolic dysfunction-associated steatotic liver disease (MASLD) reflects the central role of systemic metabolic disturbances in the pathogenesis of fatty liver. Urinary metabolic indicators may capture integrated renal, inflammatory, and metabolic alterations associated with MASLD and liver fibrosis....

Jia-Cheng Cai, Hong Wang, Lei-Lei Wang et al. · 0 citations
Review Open access Sep 2026

Association of MASLD with chronic kidney disease according to metabolic profiles and fibrosis severity: a KNHANES analysis

Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly recognized as a multisystem metabolic disorder with extrahepatic manifestations, including chronic kidney disease (CKD). However, population-level evidence on the renal impact of metabolic heterogeneity and fibrosis severity in...

Hyejin Park, S. Kim · 0 citations
Open access Oct 2026

Association between the hemoglobin albumin lymphocyte and platelet score and chronic kidney disease: Insights from patient data and animal models

Objectives The hemoglobin, albumin, lymphocytes and platelets (HALP) score, a novel nutritional and inflammatory biomarker, has been used in various chronic disease studies. However, the relationship between the HALP score and chronic kidney disease (CKD) remains poorly elucidated. This study aimed to explore the assoc...

Wen-Yu Zhang, Ya-Shi Wang, Wen-Feng Ye et al. · 0 citations
Review Open access Sep 2026

Associations of metabolic dysfunction-associated steatotic liver disease and significant fibrosis phenotypes with glomerular hyperfiltration defined by indexed eGFR

Background To examine associations of metabolic dysfunction-associated steatotic liver disease (MASLD) and significant fibrosis with glomerular hyperfiltration (GHF) defined from indexed estimated glomerular filtration rate (eGFR), accounting for body size. Methods We analyzed 9,140 NHANES participants and 721 adults f...

Wen Tian, Jia-Meng Wang, Xue-Ling Xu et al. · 0 citations
Open access Oct 2026

Novel composite renal indicators outperform traditional markers in identifying type 2 diabetes risk in middle-aged and older Chinese adults.

BACKGROUND the rising coexistence of type 2 diabetes (T2DM) and chronic kidney disease (CKD) poses a major health challenge. Traditional renal biomarkers have limitations in characterizing renal-metabolic alterations associated with prevalent T2DM. This study evaluated composite renal indicators and their associations...

Le-Tai Li, Long Li, Shi-Ying Ye et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.